Authors
Sergio Martínez-Ortega, Bruno I Benincasa, Felipe G Nishimura, Ana L Fachin, Renata Dellalibera-Joviliano, Pedro Nunez-Abades, Carmen Castro, Rene O Beleboni
Published in
Naunyn-Schmiedeberg's archives of pharmacology. Jul 20, 2026. Epub Jul 20, 2026.
Abstract
Neurodegenerative diseases (NDs) are characterized by progressive neuronal loss associated with excitotoxicity, oxidative stress, neuroinflammation, and impaired neuroplasticity. Fisetin, a naturally occurring flavonoid, has emerged as a potential neuroprotective compound due to its antioxidant and anti-inflammatory properties. In this study, we investigated the effects of fisetin in cellular models of glutamate-induced excitotoxicity and neural progenitor differentiation. Differentiated PC-12 cells were exposed to 13 mM glutamate and treated with fisetin. Cell viability was assessed using the MTT assay, reactive oxygen species (ROS) production by dihydroethidium assay, and TNF-α levels by ELISA. In parallel, subventricular zone (SVZ)-derived neurosphere cultures were used to evaluate proliferation and differentiation. Fisetin significantly attenuated glutamate-induced cytotoxicity, reduced ROS production, and decreased TNF-α levels. In neurosphere cultures, fisetin reduced neurosphere size without altering neurosphere number, suggesting modulation of progenitor cell dynamics without affecting neural stem cell self-renewal. Moreover, fisetin increased β-III-tubulin-positive neuroblasts without affecting GFAP-positive glial cells. These findings support the pharmacological potential of fisetin in modulating key pathological features of NDs and encourage further in vivo validation and molecular pathway analysis.
PMID:
42472719
Bibliographic data and abstract were imported from PubMed on 20 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0